Aurobindo Pharma Ltd

AUROPHARMA

Company Profile

  • Business description

    Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. It is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Its formulations target key therapeutic areas, including Central Nervous System (CNS), Antibiotics, Anti-diabetics, Cardiovascular, Anti-retroviral, Gastroenterology, Oncology, and Dermatology. The operating and reportable segments of the company are; India, the United States of America, Europe, and the Rest of the World. The company generates a majority of its revenue from its business in the United States of America.

  • Contact

    Plot No. 1, Survey No. 83/1
    Galaxy, Floors 22-24
    Hyderabad Knowledge City
    Raidurg Panmaktha, Ranga Reddy District
    HyderabadTG500032
    IND

    T: +91 4066725000

    https://www.aurobindo.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    40,750

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,321.1010.80-0.12%
CAC 408,218.3440.52-0.49%
DAX 4024,250.0879.95-0.33%
Dow JONES (US)46,805.29119.45-0.25%
FTSE 1009,533.18106.191.13%
HKSE25,781.77245.78-0.94%
NASDAQ22,931.8721.79-0.09%
Nikkei 22549,307.798.27-0.02%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,733.322.03-0.03%
S&P/ASX 2009,030.0010.30-0.11%
SSE Composite Index3,913.762.57-0.07%

Market Movers